Vaso (OTCMKTS:VASO) (OTCMKTS: VASO) is a medical device company specializing in non-invasive cardiovascular diagnostic and monitoring solutions. The company’s core business centers on proprietary technologies that assess arterial stiffness, central blood pressure and vascular health through pulse wave analysis. By integrating advanced sensor platforms with cloud-based analytics, Vaso enables physicians and healthcare providers to detect early signs of hypertension, arterial disease and other circulatory conditions without relying on invasive procedures.
The company’s flagship product, the VasoTrack™ device, offers clinicians a portable tool for real-time assessment of central blood pressure and pulse wave velocity. In addition, Vaso has developed the aWave™ platform, which combines oscillometric blood pressure measurement with waveform capture to generate personalized vascular health reports. These products are designed for use in hospitals, outpatient clinics and remote monitoring environments, supporting patient management in cardiology, nephrology and primary care settings.
Founded in 1991 and headquartered in Ontario, California, Vaso has built a global distribution network spanning North America, Europe, Asia and the Middle East. Over its history, the company has secured key partnerships with leading medical institutions and research centers, contributing to clinical studies on arterial stiffness and hypertension management. In recent years, Vaso has expanded its footprint through strategic alliances with regional distributors, enabling wider adoption of its diagnostic platforms in emerging markets.
Vaso’s leadership team combines expertise in medical device innovation, cardiovascular science and regulatory affairs. The executive management includes a chief executive officer with over two decades of experience in healthcare technology, a chief medical officer renowned for contributions to vascular research, and a chief financial officer with a track record in scaling small-cap medical companies. Guided by a board of directors with backgrounds in biomedical engineering and global healthcare markets, Vaso continues to advance its mission of improving patient outcomes through early detection and non-invasive cardiovascular care.
